bioMérieux S.A.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BMXMF | QGEN | ICLR | RVTY | ERF.PA | 4544.T | |
|---|---|---|---|---|---|---|
| Market cap | 11.18B | 9.68B | 12.95B | 17.05B | 13.51B | 199.33B |
| P/E (TTM) | 20.9 | 23.8 | 176.7 | 73.1 | 27.4 | 21.6 |
| Forward P/E | — | 17.9 | 14.3 | 25.9 | 17.0 | 36.1 |
| Price/book | 2.3 | 2.9 | 1.4 | 2.4 | 3.8 | 1.5 |
| Dividend yield | 1.12% | 0.76% | — | 0.18% | 0.92% | 3.36% |
| 1-year change | −21.43% | −5.22% | −9.69% | +60.15% | +22.47% | −5.83% |
| Today | −5.54% | +1.62% | −1.34% | +0.13% | +0.87% | −0.78% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.
Latest news
All BMXMF news ›bioMérieux to Showcase Company's Latest in Diagnostic Innovations at ADLM 2026
Jul 14, 2026, 11:43 ET ANAHEIM, Calif., July 14, 2026 /PRNewswire/ -- bioMérieux, a global leader in in vitro diagnostics, today announced it will showcase its latest diagnostic solutions and innovations at the 2026 Association for…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
prnewswire.com1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.